1: Ke Y, Gonthier R, Isabelle M, Bertin J, Simard JN, Dury AY, Labrie F. A rapid and sensitive UPLC-MS/MS method for the simultaneous quantification of serum androsterone glucuronide, etiocholanolone glucuronide, and androstan-3α, 17β diol 17-glucuronide in postmenopausal women. J Steroid Biochem Mol Biol. 2015 May;149:146-52. doi: 10.1016/j.jsbmb.2015.02.009. Epub 2015 Feb 18. PubMed PMID: 25701608.
2: Cawley AT, Blakey K, Waller CC, McLeod MD, Boyd S, Heather A, McGrath KC, Handelsman DJ, Willis AC. Detection and metabolic investigations of a novel designer steroid: 3-chloro-17α-methyl-5α-androstan-17β-ol. Drug Test Anal. 2016 Jul;8(7):621-32. doi: 10.1002/dta.1832. Epub 2015 Jun 23. PubMed PMID: 27443417.
3: Ewing L, Brown B. Formation and secretion of 5alpha-androstan-17beta-ol-3-one, 5alpha-androstan-3alpha,17beta-diol and 5alpha-androstan-3beta,17beta-diol by the perfused rabbit testis epididymis. Endocrinology. 1975 Feb;96(2):479-85. PubMed PMID: 1112261.
4: Ahmad MS, Zafar S, Bibi M, Bano S, Atia-Tul-Wahab, Atta-Ur-Rahman, Iqbal Choudhary M. Biotransformation of androgenic steroid mesterolone with Cunninghamella blakesleeana and Macrophomina phaseolina. Steroids. 2014 Apr;82:53-9. doi: 10.1016/j.steroids.2014.01.001. Epub 2014 Jan 22. PubMed PMID: 24462640.
5: Kiousi P, Angelis YS, Fragkaki AG, Abushareeda W, Alsayrafi M, Georgakopoulos C, Lyris E. Markers of mesterolone abuse in sulfate fraction for doping control in human urine. J Mass Spectrom. 2015 Dec;50(12):1409-19. doi: 10.1002/jms.3715. PubMed PMID: 26634976.
6: Smith C, Wahab AT, Khan MS, Ahmad MS, Farran D, Iqbal Choudhary M, Baydoun E. Microbial transformation of oxandrolone with Macrophomina phaseolina and Cunninghamella blakesleeana. Steroids. 2015 Oct;102:39-45. doi: 10.1016/j.steroids.2015.06.008. Epub 2015 Jun 18. PubMed PMID: 26095204.
7: Andrade LC, de Almeida MJ, Paixão JA, Carvalho JF, Sá E Melo ML. 3β,5α,6β-Trihy-droxy-androstan-17-one. Acta Crystallogr Sect E Struct Rep Online. 2011 May 1;67(Pt 5):o1056-7. doi: 10.1107/S1600536811011706. Epub 2011 Apr 7. PubMed PMID: 21754383; PubMed Central PMCID: PMC3089281.
8: Sunde A, Rosness PA, Eik-Nes KB. Metabolism of 5 alpha-androstane-3 beta,17 beta-diol to 17 beta-hydroxy-5 alpha-androstan-3-one and 5 alpha-androstan-3 alpha,17 beta-diol in the rat. Biochim Biophys Acta. 1979 Aug 30;574(2):240-7. PubMed PMID: 39615.
9: Ewing LL. Some factors affecting testosterone, dihydrotestosterone, 5 alpha-androstan-3 alpha,17 beta-diol and 5 alpha-androstan-3 beta,17 beta-diol secretion by invitro perfused rabbit testes. Curr Top Mol Endocrinol. 1975;2:145-64. PubMed PMID: 18320.
10: Fragkaki AG, Angelis YS, Kiousi P, Georgakopoulos CG, Lyris E. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS. J Mass Spectrom. 2015 May;50(5):740-8. doi: 10.1002/jms.3583. PubMed PMID: 26259657.
11: Purvis K, Calandra R, Haug E, Hansson V. 5alpha-reduced androgens and testicular function in the immature rat: effects of 5alpha-androstan-17beta-ol-3one (DHT) propionate and 5alpha-androstan-3alpha,17beta-diol. Mol Cell Endocrinol. 1977 May;7(3):203-19. PubMed PMID: 873044.
12: Gómez C, Pozo OJ, Marcos J, Segura J, Ventura R. Alternative long-term markers for the detection of methyltestosterone misuse. Steroids. 2013 Jan;78(1):44-52. doi: 10.1016/j.steroids.2012.10.008. Epub 2012 Nov 2. PubMed PMID: 23127819.
13: Shi R, Zhang CS, Wei K. 16α-Bromo-17β-hydr-oxy-5α-androstan-3β-yl acetate. Acta Crystallogr Sect E Struct Rep Online. 2010 Mar 6;66(Pt 4):o750. doi: 10.1107/S1600536810007555. PubMed PMID: 21580595; PubMed Central PMCID: PMC2983941.
14: Catsoulacos P, Politis D, Boutis L, Papageorgiou A. New compounds: antitumor activity of 3beta-hydroxy-13alpha-amino-13,17-seco-5alpha-androstan-17-oic-13,17-lactam 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrate. J Pharm Sci. 1978 Sep;67(9):1342-3. PubMed PMID: 690853.
15: Chen C, Li X, Singh SM, Labrie F. Activity of 17beta-(N-alkyl/arylformamido) and 17beta-[(N-alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors in the hamster flank organ and ear. J Invest Dermatol. 1998 Aug;111(2):273-8. PubMed PMID: 9699729.
16: Pohle HD. [On the tolerance of the liver for 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (mesterolone)]. Arzneimittelforschung. 1966 Apr;16(4):473-4. German. PubMed PMID: 6014253.
17: Kao LW, Crosswell MJ, Weisz J. Steroid metabolism by the lung: conversion of dihydrotestosterone to 5 alpha-androstan-3 alpha, 17 beta-diol by rat lung tissue in vitro. Endocrinology. 1979 Mar;104(3):664-6. PubMed PMID: 436725.
18: Krause W, Jakobs U. Determination of 17 beta-hydroxy-1 alpha-methyl-17 alpha-propyl-5-alpha-androstan-3-one in plasma by gas chromatography-mass spectrometry with single-ion detection. J Pharm Sci. 1984 Apr;73(4):563-4. PubMed PMID: 6726647.
19: ANSFIELD FJ, OLSON KB, RASCH O. The use of androstan-3, 11, dione-17beta-hydroxy, 17-methyl (compound NSC 19605) in the treatment of advanced breast cancer. Cancer. 1962 Mar-Apr;15:330-3. PubMed PMID: 13861731.
20: Thamotharan S, Parthasarathi V, Gupta R, Jindal DP, Linden A. Two azasteroidal [3,2-c]pyrazole derivatives: 2'-(p-fluorophenyl)-4-azapyrazolo[4',3':2,3]-5alpha-androstan-17beta-yl acetate and 2'-(p-fluorophenyl)-4-azapyrazolo[4',3':2,3]-5alpha-androstan-17beta-ol. Acta Crystallogr C. 2003 Dec;59(Pt 12):o724-6. Epub 2003 Nov 30. PubMed PMID: 14671383.